Safety, Effectiveness of VKAs, DOACs Similar in General Practice
THURSDAY, March 12, 2020 -- For patients receiving anticoagulants, arteriovenous events and major bleeding events do not differ for those receiving vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), according to a study published in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Bleeding | General Practices | Pharmaceuticals | Primary Care | Study | Vitamin K | Vitamins